Table 1 Clinicopathologic characteristics of 627 patients with R0/1 resection for ductal adenocarcinoma of the pancreas
From: AB0 blood group and prognosis in patients with pancreatic cancer
Parameter | Total | Blood group A | Blood group AB | Blood group B | Blood group O | P-value |
|---|---|---|---|---|---|---|
n | 627 | 328 | 30 | 73 | 196 | |
Age [years] | 0.58 | |||||
<70 | 430 (69%) | 224 (68%) | 24 (80%) | 50 (68%) | 132 (67%) | |
≥70 | 197 (31%) | 104 (32%) | 6 (20%) | 23 (32%) | 64 (33%) | |
Sex | 0.98 | |||||
Male | 341 (54%) | 177 (54%) | 17 (57%) | 41 (56%) | 106 (54%) | |
Female | 286 (46%) | 151 (46%) | 13 (43%) | 32 (44%) | 90 (46%) | |
Procedure | 0.16 | |||||
Pancreatico-duodenectomy | 443 (71%) | 242 (74%) | 20 (67%) | 50 (68%) | 131 (67%) | |
Distal pancreatectomy | 108 (17%) | 49 (15%) | 9 (30%) | 15 (21%) | 35 (18%) | |
Total pancreatectomy | 76 (12%) | 37 (11%) | 1 (3%) | 8 (11%) | 30 (15%) | |
Tumor size | 0.89 | |||||
pT0/1 | 9 (1%) | 5 (2%) | 1 (3%) | 1 (1%) | 2 (1%) | |
pT2 | 10 (2%) | 6 (2%) | 1 (3%) | 1 (1%) | 2 (1%) | |
pT3 | 597 (95%) | 310 (94%) | 28 (93%) | 70 (96%) | 189 (96%) | |
pT4 | 11 (2%) | 7 (2%) | 0 (0%) | 1 (1%) | 3 (2%) | |
Lymph node status | 0.37 | |||||
negative | 112 (18%) | 57 (17%) | 9 (30%) | 13 (18%) | 33 (17%) | |
positive | 515 (82%) | 271 (83%) | 21 (70%) | 60 (82%) | 163 (83%) | |
Grading | 0.68 | |||||
G1 | 19 (3%) | 9 (3%) | 2 (7%) | 2 (3%) | 6 (3%) | |
G2 | 424 (68%) | 224 (69%) | 17 (57%) | 47 (65%) | 136 (70%) | |
G3 | 180 (29%) | 93 (28%) | 11 (37%9 | 23 (32%) | 53 (27%) | |
missing values | 4 | |||||
Resection margin | 0.56 | |||||
negative | 333 (53%) | 177 (55%) | 18 (60%) | 34 (47%) | 104 (53%) | |
positive | 290 (47%) | 147 (45%) | 12 (40%) | 39 (53%) | 92 (47%) | |
missing values | 4 | |||||
CA 19–9 [U/ml] | 0.43 | |||||
<37 | 130 (22%) | 34 (19%) | 20 (29%) | 6 (21%) | 70 (23%) | |
≥37 | 457 (78%) | 145 (81%) | 50 (71%) | 23 (79%) | 239 (77%) | |
missing values | 40 | |||||
Rhesus factor | 0.40 | |||||
positive | 521 (83%) | 267 (81%) | 28 (93%) | 62 (85%) | 164 (84%) | |
negative | 106 (17%) | 61 (19%) | 2 (7%) | 11 (15%) | 32 (16%) |